{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:11:46Z","timestamp":1784131906962,"version":"3.55.0"},"reference-count":61,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,5,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with adult T-cell leukemia (ATL) exhibit a poor prognosis and overall survival rate when treated with standard chemotherapy, highlighting the continued requirement for the development of novel safe and effective therapies for human T-cell leukemia virus type 1 (HTLV-1)-related diseases. In this study, we demonstrated that MK-2048, a second-generation HIV-1 integrase (IN) inhibitor, potently and selectively kills HTLV-1\u2013infected cells. Differential transcriptome profiling revealed significantly elevated levels of gene expression of the unfolded protein response (UPR) PKR-like ER kinase (PERK) signaling pathway in ATL cell lines following MK-2048 treatment. We also identified a significant downregulation in glucose regulated protein 78 (GRP78), a master regulator of the UPR in the CD4+CADM1+ HTLV-1\u2013infected cell population of primary HTLV-1 carrier peripheral blood mononuclear cells (PBMCs) (n = 9), suggesting that HTLV-1\u2013infected cells are hypersensitive to endoplasmic reticulum (ER) stress-mediated apoptosis. MK-2048 efficiently reduced proviral loads in primary HTLV-1 carrier PBMCs (n = 4), but had no effect on the total numbers of these cells, indicating that MK-2048 does not affect the proliferation of HTLV-1\u2013uninfected PBMCs. MK-2048 specifically activated the ER stress\u2013related proapoptotic gene, DNA damage-inducible transcript 3 protein (DDIT3), also known as C\/EBP homologous protein (CHOP), in HTLV-1\u2013infected but not uninfected cells of HTLV-1\u2013carrier PBMCs. Our findings demonstrated that MK-2048 selectively induces HTLV-1\u2013infected cell apoptosis via the activation of the UPR. This novel regulatory mechanism of the HIV IN inhibitor MK-2048 in HTLV-1\u2013infected cells provides a promising prophylactic and therapeutic target for HTLV-1\u2013related diseases including ATL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001139","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T15:34:06Z","timestamp":1588692846000},"page":"1845-1858","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1\u2013infected cells"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0285-0466","authenticated-orcid":false,"given":"Emi","family":"Ikebe","sequence":"first","affiliation":[{"name":"Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahoko","family":"Matsuoka","sequence":"first","affiliation":[{"name":"Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Tezuka","sequence":"first","affiliation":[{"name":"Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Kuramitsu","sequence":"first","affiliation":[{"name":"Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazu","family":"Okuma","sequence":"first","affiliation":[{"name":"Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakashima","sequence":"first","affiliation":[{"name":"Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-4537","authenticated-orcid":false,"given":"Seiichiro","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Division of Molecular Therapy, Institute of Medical Science, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0883-2920","authenticated-orcid":false,"given":"Junya","family":"Makiyama","sequence":"first","affiliation":[{"name":"Department of Hematology\/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamagishi","sequence":"first","affiliation":[{"name":"Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Oyadomari","sequence":"first","affiliation":[{"name":"Division of Molecular Biology, Institute for Genome Research, Tokushima University, Tokushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Uchimaru","sequence":"first","affiliation":[{"name":"Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences,"},{"name":"Department of Hematology\/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Hamaguchi","sequence":"first","affiliation":[{"name":"Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"issue":"10","key":"2020050511340139300_B1","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2020050511340139300_B2","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2020050511340139300_B3","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8452","key":"2020050511340139300_B4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"issue":"8488","key":"2020050511340139300_B5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"issue":"3","key":"2020050511340139300_B6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1349-7006.1992.tb00092.x","article-title":"HTLV-I uveitis: a distinct clinical entity caused by HTLV-I","volume":"83","author":"Mochizuki","year":"1992","journal-title":"Jpn J Cancer Res"},{"issue":"3","key":"2020050511340139300_B7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"issue":"34","key":"2020050511340139300_B8","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"2020050511340139300_B9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1704827","article-title":"Mogamulizumab (anti-CCR4) in HTLV-1-associated myelopathy","volume":"378","author":"Sato","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"2020050511340139300_B10","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J Clin Oncol"},{"issue":"8","key":"2020050511340139300_B11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J Clin Oncol"},{"issue":"34","key":"2020050511340139300_B12","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","article-title":"Multicenter phase II study of lenalidomide in relapsed or recurrent adult T-cell leukemia\/lymphoma: ATLL-002","volume":"34","author":"Ishida","year":"2016","journal-title":"J Clin Oncol"},{"key":"2020050511340139300_B13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fmicb.2018.00278","article-title":"How to control HTLV-1-associated diseases: preventing de novo cellular infection using antiviral therapy","volume":"9","author":"Pasquier","year":"2018","journal-title":"Front Microbiol"},{"issue":"27","key":"2020050511340139300_B14","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"issue":"8","key":"2020050511340139300_B15","first-page":"2849","article-title":"Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation","volume":"96","author":"El-Sabban","year":"2000","journal-title":"Blood"},{"issue":"19","key":"2020050511340139300_B16","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2010-02-270751","article-title":"Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors","volume":"116","author":"Afonso","year":"2010","journal-title":"Blood"},{"issue":"12","key":"2020050511340139300_B17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/bloodadvances.2016001370","article-title":"Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-\u03b1","volume":"1","author":"Macchi","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"2020050511340139300_B18","doi-asserted-by":"crossref","first-page":"e1400203","DOI":"10.1126\/sciadv.1400203","article-title":"Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia","volume":"1","author":"Tada","year":"2015","journal-title":"Sci Adv"},{"issue":"10","key":"2020050511340139300_B19","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1128\/AAC.01361-07","article-title":"Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication","volume":"52","author":"Rabaaoui","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2020050511340139300_B20","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/AAC.01413-10","article-title":"Integrase inhibitors effective against human T-cell leukemia virus type 1","volume":"55","author":"Seegulam","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2020050511340139300_B21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jac\/dkr404","article-title":"Antiviral effect of raltegravir on HTLV-1 carriers","volume":"67","author":"Trevi\u00f1o","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2020050511340139300_B22","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1038\/bcj.2016.21","article-title":"Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma","volume":"6","author":"Ratner","year":"2016","journal-title":"Blood Cancer J"},{"issue":"20","key":"2020050511340139300_B23","doi-asserted-by":"crossref","first-page":"18077","DOI":"10.1074\/jbc.M110164200","article-title":"Ultraviolet light inhibits translation through activation of the unfolded protein response kinase PERK in the lumen of the endoplasmic reticulum","volume":"277","author":"Wu","year":"2002","journal-title":"J Biol Chem"},{"issue":"21","key":"2020050511340139300_B24","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1128\/MCB.22.21.7405-7416.2002","article-title":"Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha","volume":"22","author":"Koumenis","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"1-2","key":"2020050511340139300_B25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2006.09.011","article-title":"Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response","volume":"124","author":"Li","year":"2007","journal-title":"Virus Res"},{"key":"2020050511340139300_B26","doi-asserted-by":"crossref","first-page":"101047","DOI":"10.1016\/j.redox.2018.11.005","article-title":"Redox signaling and unfolded protein response coordinate cell fate decisions under ER stress","volume":"25","author":"Zhang","year":"2019","journal-title":"Redox Biol"},{"key":"2020050511340139300_B27","first-page":"857516","article-title":"Endoplasmic reticulum stress: its role in disease and novel prospects for therapy","volume":"2012","author":"Sch\u00f6nthal","year":"2012","journal-title":"Scientifica (Cairo)"},{"issue":"6","key":"2020050511340139300_B28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/35014014","article-title":"Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response","volume":"2","author":"Bertolotti","year":"2000","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2020050511340139300_B29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1534-5807(02)00203-4","article-title":"ER stress regulation of ATF6 localization by dissociation of BiP\/GRP78 binding and unmasking of Golgi localization signals","volume":"3","author":"Shen","year":"2002","journal-title":"Dev Cell"},{"issue":"8","key":"2020050511340139300_B30","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1158\/0008-5472.CAN-07-0325","article-title":"GRP78 induction in cancer: therapeutic and prognostic implications","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res"},{"issue":"4","key":"2020050511340139300_B31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc3701","article-title":"Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential","volume":"14","author":"Lee","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2020050511340139300_B32","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.humpath.2007.11.009","article-title":"Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas","volume":"39","author":"Zheng","year":"2008","journal-title":"Hum Pathol"},{"issue":"6","key":"2020050511340139300_B33","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/ijc.28137","article-title":"The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer","volume":"133","author":"Thornton","year":"2013","journal-title":"Int J Cancer"},{"issue":"3","key":"2020050511340139300_B34","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1182\/blood-2011-06-357384","article-title":"Inducible knockout of GRP78\/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling","volume":"119","author":"Wey","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2020050511340139300_B35","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.18632\/oncotarget.3075","article-title":"Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma","volume":"6","author":"Abdel Malek","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"2020050511340139300_B36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12885-015-1460-1","article-title":"Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment","volume":"15","author":"Adomako","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"2020050511340139300_B37","doi-asserted-by":"crossref","first-page":"16067","DOI":"10.1038\/srep16067","article-title":"Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer","volume":"5","author":"Niu","year":"2015","journal-title":"Sci Rep"},{"issue":"6","key":"2020050511340139300_B38","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1084\/jem.162.6.2169","article-title":"Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement","volume":"162","author":"Maeda","year":"1985","journal-title":"J Exp Med"},{"issue":"4561","key":"2020050511340139300_B39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.6980467","article-title":"Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line","volume":"217","author":"Yamamoto","year":"1982","journal-title":"Science"},{"issue":"2","key":"2020050511340139300_B40","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1182\/blood.V64.2.482.482","article-title":"Characterization of a novel HTLV-infected cell line","volume":"64","author":"Koeffler","year":"1984","journal-title":"Blood"},{"issue":"11","key":"2020050511340139300_B41","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-13-3169","article-title":"CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia\/lymphoma","volume":"20","author":"Kobayashi","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2020050511340139300_B42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-mediated loss of miR-31 activates NIK-dependent NF-\u03baB pathway in adult T cell leukemia and other cancers","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"2020050511340139300_B43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12977-015-0199-8","article-title":"Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo","volume":"12","author":"Hiyoshi","year":"2015","journal-title":"Retrovirology"},{"issue":"1","key":"2020050511340139300_B44","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.182.1.466","article-title":"CHAC1\/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade","volume":"182","author":"Mungrue","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"2020050511340139300_B45","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.embor.7400779","article-title":"Mediators of endoplasmic reticulum stress-induced apoptosis","volume":"7","author":"Szegezdi","year":"2006","journal-title":"EMBO Rep"},{"issue":"8","key":"2020050511340139300_B46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/abbs\/gmu048","article-title":"New insights into the roles of CHOP-induced apoptosis in ER stress","volume":"46","author":"Li","year":"2014","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"7","key":"2020050511340139300_B47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1101\/gad.12.7.982","article-title":"CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum","volume":"12","author":"Zinszner","year":"1998","journal-title":"Genes Dev"},{"issue":"33","key":"2020050511340139300_B48","doi-asserted-by":"crossref","first-page":"29127","DOI":"10.1074\/jbc.M110.169771","article-title":"Unfolded protein response is required in nu\/nu mice microvasculature for treating breast tumor with tunicamycin","volume":"286","author":"Banerjee","year":"2011","journal-title":"J Biol Chem"},{"issue":"16","key":"2020050511340139300_B49","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1021\/jm300713s","article-title":"Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)","volume":"55","author":"Axten","year":"2012","journal-title":"J Med Chem"},{"issue":"1","key":"2020050511340139300_B50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3960\/jslrt.52.17","article-title":"CADM1\/TSLC1 is a novel cell surface marker for adult T-cell leukemia\/lymphoma","volume":"52","author":"Nakahata","year":"2012","journal-title":"J Clin Exp Hematop"},{"issue":"6","key":"2020050511340139300_B51","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/leu.2011.379","article-title":"Clinical significance of CADM1\/TSLC1\/IgSF4 expression in adult T-cell leukemia\/lymphoma","volume":"26","author":"Nakahata","year":"2012","journal-title":"Leukemia"},{"issue":"8","key":"2020050511340139300_B52","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0968-0004(01)01908-9","article-title":"The glucose-regulated proteins: stress induction and clinical applications","volume":"26","author":"Lee","year":"2001","journal-title":"Trends Biochem Sci"},{"issue":"61","key":"2020050511340139300_B53","doi-asserted-by":"crossref","first-page":"31920","DOI":"10.18632\/oncotarget.25886","article-title":"Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics","volume":"9","author":"Asha","year":"2018","journal-title":"Oncotarget"},{"key":"2020050511340139300_B54","doi-asserted-by":"crossref","first-page":"3519158","DOI":"10.1155\/2017\/3519158","article-title":"XBP1-mediated BiP\/GRP78 upregulation copes with oxidative stress in mosquito cells during dengue 2 virus infection","volume":"2017","author":"Chen","year":"2017","journal-title":"BioMed Res Int"},{"issue":"1","key":"2020050511340139300_B55","doi-asserted-by":"crossref","first-page":"e2556","DOI":"10.1038\/cddis.2016.394","article-title":"Japanese encephalitis virus induces human neural stem\/progenitor cell death by elevating GRP78, PHB and hnRNPC through ER stress","volume":"8","author":"Mukherjee","year":"2017","journal-title":"Cell Death Dis"},{"issue":"17","key":"2020050511340139300_B56","doi-asserted-by":"crossref","first-page":"17158","DOI":"10.1074\/jbc.M312144200","article-title":"Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response","volume":"279","author":"Tardif","year":"2004","journal-title":"J Biol Chem"},{"issue":"8","key":"2020050511340139300_B57","doi-asserted-by":"crossref","first-page":"e1003544","DOI":"10.1371\/journal.ppat.1003544","article-title":"Cytomegalovirus downregulates IRE1 to repress the unfolded protein response","volume":"9","author":"Stahl","year":"2013","journal-title":"PLoS Pathog"},{"issue":"7","key":"2020050511340139300_B58","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1128\/JVI.02191-06","article-title":"Maintenance of endoplasmic reticulum (ER) homeostasis in herpes simplex virus type 1-infected cells through the association of a viral glycoprotein with PERK, a cellular ER stress sensor","volume":"81","author":"Mulvey","year":"2007","journal-title":"J Virol"},{"issue":"8","key":"2020050511340139300_B59","doi-asserted-by":"crossref","first-page":"e74420","DOI":"10.1371\/journal.pone.0074420","article-title":"Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts","volume":"8","author":"Leclerc","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"2020050511340139300_B60","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1038\/oncsis.2015.18","article-title":"Metformin induces ER stress-dependent apoptosis through miR-708-5p\/NNAT pathway in prostate cancer","volume":"4","author":"Yang","year":"2015","journal-title":"Oncogenesis"},{"issue":"1","key":"2020050511340139300_B61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-4690-10-40","article-title":"LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription","volume":"10","author":"Tang","year":"2013","journal-title":"Retrovirology"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/9\/1845\/1727188\/advancesadv2019001139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/9\/1845\/1727188\/advancesadv2019001139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:44:07Z","timestamp":1615596247000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/9\/1845\/454760\/Activation-of-PERKATF4CHOP-pathway-as-a-novel"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,5,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001139","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]}}}